- Aspen Dental targets fast-growing Georgia city for new practice
- Michael Dowling: Now is not the time to abandon gun safety efforts
- A new wording test on ‘Medicare for All’
- UCI Health started as 1 hospital. 50 years and 6 hospitals later, CEO charts its future
- Virtua Health names president of 2 New Jersey hospitals
- Colorado wildfires send dozens to UCHealth hospitals
- Northwell appoints chair of surgery
- How 5 health systems are avoiding a repeat of the 2023 chemo shortage
- Nashville General taps CEO
- NewYork-Presbyterian rolls out OpenEvidence AI across its network
- Oswego Health expands surgery, orthopedic services New York
- Vanderbilt professor elected 40th president of bariatric group
- The ASC tax squeeze is gaining momentum
- The private equity race regulators haven’t caught up to
- Weill Cornell taps new chair of surgery, surgeon-in-chief
- The state-by-state battle over anesthesia time caps
- What happens to ASC contracts when a payer gets absorbed
- What will make or break the future of DSO success
- Dentistry reaches inflection point with AI
- Former UPMC cardiologist drops lawsuit over CEO’s device company ties
- Dental assistant pay vs. cost of living by state
- South Carolina cites behavioral health facility over missing correction plan
- Former Mayo Clinic research director sues system over alleged retaliation for raising AI practice concerns
- Senators urge Defense Department to expand autism therapy coverage under Tricare
- GI consolidation’s new era: 5 deals to know
- The GI procedure cuts in CMS’ pay proposal: 5 things to know
- ‘The economics just don’t work’: CMS’ ACCESS model draws scrutiny
- Washington restricts spit hood use in state psychiatric facilities
- Memorial Hermann Health Plan winds down commercial coverage
- Remarks at the Society for Corporate Governance Conference
- Maryland health system receives $10M gift to construct ASC
- 1-800-Dentist faces class-action lawsuit over data breach
- Staten Island hospital debuts mobile behavioral health program for youth
- CVS' Omnicare unit agrees to $440M settlement with DOJ in ongoing fraud case
- GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs
- Founder of telehealth startup Done sentenced to six years in prison for Adderall fraud scheme
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- Former exec alleges Alignment Healthcare leaders juiced profits to boost bonuses
- In compensation push, HHS gears up to draft COVID vaccine injury table
- AZ, Ionis shares tumble on ATTR-CM trial flop, but analyst flags over-reaction
- Frazier Healthcare Partners to acquire MatrixCare in $490M deal
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- Ipsen’s Botox rival Dysport charts new horizons with dual phase 3 wins in migraine
- Affordable Care Act Insurers Want More Premium Increases As Enrollment Sags
- My Search for a Psychiatric Bed in an Overburdened Health System
- Dr. Reddy's presses pause on generic semaglutide supply after flagging API issue
- OpenEvidence launches medical AI copilot feature that grades medical evidence and unveils NewYork-Presbyterian collaboration
- Novo Nordisk asks public to ‘Meet Me in the Middle’ in new obesity experience installation
- BioNTech plots right-sized HER2 ADC launch to ‘build the muscle’ for BMS-partnered bispecific
- Telehealth ex-CEO sentenced in Adderall fraud case: 5 things to know
- Oklahoma awards 4 behavioral health clinic contracts
- The key to patient trust in dentistry
- Good news, bad news for the dental workforce
- 7 behavioral health layoffs to know | 2026
- 200+ dentists making headlines halfway through 2026
- How students are paying for dental school
- Health tech startup Forus inks partnership with GI medical society to improve medication access
- U of Kentucky dental dean receives top educator award
- UnitedHealthcare unveils Lifestyle Spending Accounts for employer plans
- FDA hits Lundbeck with untitled letter over efficacy claims on migraine drug Vyepti
- Sanofi floats flu shot marketing pledges to pacify EU antitrust probe
- 36 behavioral health executive moves to know
- Delaware establishes statewide opioid treatment guidance for EDs
- Tampa General Hospital sues Eli Lilly over pulled 340B discounts
- Viz.ai expands neurodegenerative disease care in new partnership with Cortechs.ai
- E. Coli Outbreak Prompts Recall Of Frozen Blueberries At Publix
- Drinking Coffee May Lower Your Risk of Liver Disease
- FDA halts release of new drug rejection letters while working to formalize policy
- Mass General Brigham nurses, home care clinicians launch largest healthcare strike in state history
- ACA plans set for another year of premium spikes, preliminary filings show
- AI wearables company Vilo launches Signal OS ahead of upcoming smart ring launch
- CureDuchenne lights the candles with DMD public service campaign highlighting birthdays
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Foreign drugmaker caught faking doctors’ petition to evade China’s price cut scheme
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Keenova gets on the good foot with Xiaflex trial win in rare tissue growth condition
- Evonik plugs $100M into Indiana drug substance plant as US CDMO demand mounts
- Rumination Plays Key Role In Caregiver Stress, Study Says
- U.S. Teens Underestimate Risks Of Fentanyl Use, Survey Finds
- Men More Likely To Be Diagnosed With Advanced Cancer
- Primary care’s AI moment
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Training Program Could Ward Off Injuries Among Soccer Girls
- Affordable Care Act Insurers Want More Premium Increases as Enrollment Sags
- Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- Leo Cancer Care secures $65M to advance upright radiotherapy system as company preps for IPO
- Catalent sells UK facility to Codis, expands Nanoscope partnership
- Allergan Aesthetics helps map paths for young women in STEM with Girls Inc. event
- Nonprofit-private equity joint ventures worth scrutiny, PESP report says
- Lenz Therapeutics rolls out telehealth offering for Vizz prescription eye drops
- American Heart Association joins social network Roon for medical research collaboration
- Independent pharmacies hit Prime Therapeutics with antitrust suit over alleged price fixing
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Michigan, Other States See Unusual Spike In Parasite That Causes 'Explosive' Diarrhea
- Statement on the 2026 Regulatory Agenda
- GLP-1 'Secret Shopper' Study Finds Gaps in Online Prescribing
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- Novartis dismisses 322 more staffers based out of US headquarters
- Bristol lays out KRAS med Krazati's stumble in confirmatory colorectal cancer trial
- Fatty Liver Boosts Odds Of More Deadly Colon Cancer, Study Says
- Weight Loss Surgery Increases Risk Of Alcoholism, Study Says
- IV Vitamin C Might Boost Recuperation Among Trauma Patients
- These Church Members Disagree On Politics. Together They're Wiping Out Medical Debt.
- Exercise Can Ward Off Nicotine Fits, Help Smokers Quit
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- On heels of Bain buyout, Tanabe inks deal to sell manufacturing unit and 17 drugs to Towa
- FDA approves Vera’s dual-target Trutakna, setting up IgAN market battle with Novartis, Otsuka
- Vertex, in its largest-ever deal, acquires endocrine disease specialist Crinetics for $10B
- Real Chemistry snaps up Spurwing Communications, launches new Asia Pacific hub
- Skin quality driving widespread quality-of-life issues: survey
- AI care partner Heidi puts a spin on pharma ad tropes in new campaign to relieve 'side effects'
- Nonprofit hospitals are embracing high-risk, high-reward investment portfolios. Is that a problem?
- New California Law Replaces 'Sell By' Labels On Food Packaging
- Study Raises New Questions About Artificial Sweeteners
- Teladoc Health inks multi-year virtual care deal with National Basketball Players Association
- FDA deepens Vertex's Casgevy label, opening treatment for patients as young as 2
- Calling Low-Risk Prostate Cancer Something Else Might Save More Lives, Researchers Argue
- Taking Small Breaks From Sitting Around Can Lower Your Cancer Risk
- Learning Languages Could Net You A Younger Brain, Study Says
- New Disease Threats Follow Trump Administration's Health Program Cuts
- New Medicaid Work Rule Means More Opportunities To Lose Coverage
- In California Governor’s Race, Voters Face Stark Choice on Immigrant Healthcare
- Epic plans to expand 4 executives' roles as President Sumit Rana exits the company
- Journalists Discuss Healthcare Costs’ Political Fallout, Concerns About Canceled ICE Facility
- FDA Lets 20 ZYN Nicotine Pouches Claim Lower Risk Than Cigarettes; Critics Warn Of Danger
- Ultra-Processed Foods Linked To Brain Differences In Young Children
- Prompt Responses From Mom Might Lower A Baby's Risk Of Childhood Mental Health Problems
- Rehab Program Helps Lift Long COVID 'Brain Fog'
- Why Are You Right- Or Left-Handed? Experiments Suggest Surprisingly Simple Explanation
- Rural Americans More Likely To View Cancer As A Death Sentence, Poll Finds
- He Dreamed Of Becoming A Physician Assistant. New Loan Rules May Thwart Him.
- HealthQ Special: Caregiving in the Sandwich Generation
- A Mom Said Infant Formula Killed Her Baby. The Manufacturer Closed the File.
- FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel
- Regulatory tracker: AbbVie, Genmab's blood cancer bispecific expands label in EU
- Can A Popular Muscle Supplement Help Treat Depression?
- Melatonin Shows Promise As Safe, Cheap Painkiller, Review Concludes
- Heat Dome Coming: Tips To Stay Safe During Extreme Temps
- Diets That Lower Inflammation Might Cut Dementia Risk, Study Indicates
- Vitamins Might Be Key To Asthma Control In Children, Adults
- Remarks at the Economic Club of New York
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
Michigan healthcare freedom community forum
The National Institutes of Health (NIH) shut down a Tony Fauci funding program, The Centers for Research in Emerging Infectious Diseases (CREID), last summer. CREID was Fauci's vehicle to finance Peter Daszak, whose EcoHealth Alliance was found to be financing the Wuhan Institute of Virology in Communist China:
https://disinformationchronicle.substack.com/p/congress-forces-nih-to-reverse-policy
Congress Forces NIH to Reverse Policy, Continue Funding Fauci’s “Unsafe” Infectious Disease Centers
HHS official expresses alarm at universities playing politics with Americans’ safety.
Paul D. Thacker - February 25, 2026The lobbyists always win.
Last summer, the National Institutes of Health sent out notices to shut down a Tony Fauci initiative launched in 2020 called the Centers for Research in Emerging Infectious Diseases or “CREID” after deeming them unsafe for Americans and not a good use of taxpayer funding.
Well, university lobbyists have struck back—managing to slip language into the congressional appropriations bill that forces NIH to spend $18.2 million to fund CREID centers once again.
A senior official with the Department of Health and Human Services (HHS) who did not wish to be named said they are unsure how university lobbyists managed to insert this demand into the funding bill, and expressed anger that Congress and universities were, as they saw it, playing politics with Americans’ safety. “The NIH is committed to never again funding dangerous pandemic activities,” said the HHS official. “The New CREID program will not fund the collection of dangerous pathogens from places like bat caves in China.”
Two researchers who were awarded the Fauci CREID grants were Kristian Andersen of Scripps Research and Peter Daszak of the nonprofit EcoHealth Alliance.
Months before Fauci signed off on Andersen’s CREID award, Andersen and other researchers published a paper in Nature Medicine titled “Proximal Origin” that dismissed the possibility of a Wuhan lab accident. House Republicans charged that Fauci helped orchestrate Andersen’s “Proximal Origin” paper. House Democrats, however, published a report arguing that Jeremy Farrar, now chief scientist with the World Health Organization, “led the drafting process of [Andersen’s] paper” and helped to organize it.
In a recent interview with The DisInformation Chronicle, virologist and former CDC Director Robert Redfield said Andersen’s “Proximal Origin” paper is scientific fraud that should be retracted. The group BioSafety Now has also demanded that Nature Medicine retract the paper, calling it “a product of scientific misconduct.”
In the final days of the Biden Administration, HHS debarred Peter Daszak and the nonprofit EcoHealth Alliance from receiving federal funds.
Just 10 days ago, Andersen was still complaining on Bluesky about the loss of his CREID grant that the NIH deemed “unsafe for Americans.”
“We will absolutely abide by the President’s executive order to not fund dangerous gain-of-function research,” said the senior HHS official.
As previously reported at The DisInformation Chronicle, the White House is finalizing Trump’s plan to deal with dangerous gain-of-function virus research as laid out in a May 2025 executive order. The new policy will take a risk-based approached to determine whether a pathogen study will be funded. Scientists who fail to disclose dangerous research could be barred from federal programs as could their universities.
Dear Readers: University lobbyists have been gaming the federal funding system for decades, playing the White House and Congress off each other to put more money in the pockets of college administrators. If you’re interested in learning more, take a look at this recent deep-dive I wrote for RealClearInvestigations: “The Trump Administration’s Fight To Fund Scientists.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
























